,KIM-1

Clara Steiner1, Marc Machaalani1, Joseph V Bonventre2

  • 1Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

PubMed
概括

损伤分子-1 (KIM-1) 显示为细胞癌的非侵入性生物标志物具有前途. 进一步的前性研究对于验证KIM-1在癌诊断中的临床使用至关重要.